Merck Enters into Licensing Deal with Five Indian Companies for Supply of Oral Covid-19 Drug
Recently, Merck, also known as MSD, has entered into licensing agreements with five Indian generics drug manufacturers to manufacture and supply oral Covid-19 drug Molnupiravir. MSD India is a wholly-owned subsidiary of Merck Sharp & Dohme (MSD) and is known as Merck & Co., Inc, in the United States and Canada. Under the agreements, Merck will provide […]
Battle of the Brands: Gilead Sciences Inc. vs. Merck & Co. Inc
The legal dispute between the two pharmaceutical majors Gilead Sciences Inc. and Merck & Co. Inc. involving Hepatitis C drugs clearly indicates the high stakes involved when it comes to intellectual property. It all began in 2013, back in the day when Gilead Sciences Inc, filed for a New Drug application (NDA) with the FDA […]
Inventors – All Technologies Are not Worth Billions
Working in the IP/Technology Commercialization and Out-Licensing domain makes you assess and evaluate the commercial viability of numerous IP backed inventions across technology domains. Apart from learning about and assessing new technologies, we also tend to learn quite a lot about Inventors’ mindset, specifically about their perspective of their own inventions. This article relates to […]
Inventors – All Technologies Are not Worth Billions
Working in the IP/Technology Commercialization and Out-Licensing domain makes you assess and evaluate the commercial viability of numerous IP backed inventions across technology domains. Apart from learning about and assessing new technologies, we also tend to learn quite a lot about Inventors’ mindset, specifically about their perspective of their own inventions. This article relates to […]